Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Transplant Indication”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableEnrolling By InvitationNCT05540197
What this trial is testing

Arginine-stimulated Indication of Early Outcome After Islet Transplantation

Who this might be right for
Islets of Langerhans TransplantationDiabetes MellitusChronic Pancreatitis
Leiden University Medical Center 30
Not applicableNot Yet RecruitingNCT06507800
What this trial is testing

Cancer as a complicATion in reCipients of Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease iNdiCation trEated in FRance and Canada?

Who this might be right for
Autoimmune Diseases
Assistance Publique - Hôpitaux de Paris 500
Not applicableUnknownNCT01702051
What this trial is testing

Extending Indication for Islet Autotransplantation in Pancreatic Surgery

Who this might be right for
Diabetes
Ospedale San Raffaele 150
Not applicableStudy completedNCT03675997
What this trial is testing

GRAFted Patients' anxieTY Report

Who this might be right for
Autologous Transplant Indication
Institut de Cancérologie de la Loire 30
Testing effectiveness (Phase 2)UnknownNCT03315520
What this trial is testing

BeEAC Conditioning Regimen in Malignant Lymphoma Subjects With Indications to Autologous Hematopoietic Stem-cell Transplantation

Who this might be right for
Relapsed/Refractory Malignant Lymphomas
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia 100
Testing effectiveness (Phase 2)Looking for participantsNCT04276870
What this trial is testing

Orphan Indications for CD19 Redirected Autologous T Cells

Who this might be right for
Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALLInfants With Very High Risk KMT2A B-ALLPatients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation
Stephan Grupp MD PhD 133